501072-44-2

4,6-Octadien-1-yn-3-one, 1-(trimethylsilyl)-, (4E,6E)-

2-phenylethyl 2-bromobutanoate

Benzamide,N-[3,5-bis(trifluoromethyl)phenyl]-5-[(dimethylamino)sulfonyl]-2-hydroxy-

3-Pyridinecarboxamide,2-(7-isoquinolinylamino)-N-(2-methyl-5-benzothiazolyl)-

2-deoxy-2-(~18~F)fluoro-D-glucose

2-acetyl-n-[1-[3-[(3,4-dimethoxyphenyl)methyl]-5-oxo-2h-1,2,4-triazin-6-yl]ethyl]-5-phenylpentanamide

(R)-(-)-DENOPAMINE HYDROCHLORIDE

1,3,4-Oxadiazole-2(3H)-thione,3-[(diphenylamino)methyl]-5-(2-hydroxyphenyl)-

2-Benzothiazolamine, 6-methoxy-N-(4-methoxyphenyl)-

(3S)-3-(2-oxo-1-pyrrolidinyl)-1-Piperidinecarboxylic acid 1,1-dimethylethyl ester

Omeprazole free base (racemic)

3-Pyridinecarboxamide, 2-fluoro-N-[4-(pentafluoroethyl)phenyl]-

Urea,N-(2-bromo-4-methylphenyl)-N'-(4,5,6,7-tetrahydrobenzo[b]thien-4-yl)-

1,9,17-Cyclotetracosatriene

N-benzyl-2-tert-butyl-5-hydroxy-4-methyl-3-oxoisoindoline-1-carboxamide

Carbonic acid, 1-(4-chlorophenyl)-2-propenyl methyl ester

(2S)-2-amino-3-(3-{(E)-2-[(2S)-2,6-dicarboxy-2,3-dihydropyridin-4-yl]ethenyl}-1H-imidazol-3-ium-5-yl)propanoate

Acetic acid, diazo(trimethylsilyl)-, phenylmethyl ester

6-[(tert-butyldiphenylsilyl)oxy]-1-indanone

2-[(3,4-dimethoxyphenyl)methyl]-5-methyl-7-(2-oxo-6-phenylhexan-3-yl)-1h-imidazo[5,1-f][1,2,4]triazin-4-one

Benzenemethanamine, N-(2-methyl-3-nitrophenyl)-

(aZ)-2-Amino-5-chloro-a-(hydroxyimino)-4-thiazoleacetic acid ethyl ester monohydrochloride

5-METHYLTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE

3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydroPyridine

tert-Butyl (4-cyano-5-methoxypyridin-3-yl)-methylcarbamate

N-[1,1-dimethyl-4-(4-methylpiperazin-1-yl)but-2-yn-1-yl]-10H-phenothiazine-10-carboxamide dihydrochloride

Cyclopenta[b]pyrrol-6(1H)-one, hexahydro-1-methyl-, cis-

9-Heptadecynoic acid, methyl ester

4-[2-(3,4-dihydroxyphenyl)-2-oxoethyl]-4-methylmorpholin-4-ium

Isoquinoline,4-(2-fluoro-4-methoxyphenyl)-1,2,3,4-tetrahydro-2-methyl-7-[[1-(2-methylpropyl)-4-piperidinyl]methoxy]-

Piperidine,4-[[[1,2,3,4-tetrahydro-4-(4-methoxyphenyl)-2-methyl-7-isoquinolinyl]oxy]methyl]-1-(trifluoroacetyl)-

Pyrazinecarboxamide,3-amino-N-methyl-6-[3-[[[[4-(methylsulfonyl)phenyl]methyl]amino]carbonyl]phenyl]-

1H-1,4-Benzodiazepine-3-acetamide,4-[(2,3-dichlorophenyl)sulfonyl]-2,3,4,5-tetrahydro-2-oxo-N-[2-(4-pyridinyl)ethyl]-

Isoquinoline,7-[3-(4-fluoro-1-piperidinyl)propoxy]-1,2,3,4-tetrahydro-2-methyl-4-phenyl-

3-Amino-2-methyl-4-oxo-azetidine-1-sulfonic acid

ethanesulfonic acid - 2-[4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]-N,N-diethylacetamide (1:1)

Benzeneacetic acid,3-[4-[3-(1-methylethyl)-1-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-4-yl]butoxy]-

501072-44-2 msds

CAS No 501072-44-2 supplier

CASNo 501072-44-2 distributor

CAS # 501072-44-2 manufacturer

CAS Number 501072-44-2 safety

CAS RN 501072-44-2 wholesale

2026-10-10 Find 4,6-Octadien-1-yn-3-one, 1-(trimethylsilyl)-, (4E,6E)-,CAS No.501072-44-2,Formula:C11H16OSi in APGChem